Published in
Elsevier, The Lancet Respiratory Medicine, 5(5), p. 435-444
DOI: 10.1016/s2213-2600(17)30129-7
Links
Tools
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
Journal article published in 2017 by
Rafael Rosell,
Urania Dafni,
Enriqueta Felip,
Alessandra Curioni-Fontecedro,
Oliver Gautschi,
Solange Peters,
Bartomeu Massutí 
,
Ramon Palmero,
Santiago Ponce Aix,
Enric Carcereny,
Martin Früh,
Miklos Pless,
Sanjay Popat,
Athanasios Kotsakis,
Sinead Cuffe
and other authors.
,
Ramon Palmero,
Santiago Ponce Aix,
Enric Carcereny,
Martin Früh,
Miklos Pless,
Sanjay Popat,
Athanasios Kotsakis,
Sinead Cuffe
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 